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Summary:
With multiple possible mediators on the causal pathway from a treatment to an outcome, we consider the problem
of decomposing the effects along multiple possible causal path(s) through each distinct mediator. Under Pearl’s path-
specific effects framework (Pearl, 2001; Avin et al., 2005), such fine-grained decompositions necessitate stringent
assumptions, such as correctly specifying the causal structure among the mediators, and no unobserved confounding
among the mediators. In contrast, interventional direct and indirect effects for multiple mediators (Vansteelandt and
Daniel, 2017) can be identified under much weaker conditions, while providing scientifically relevant causal inter-
pretations. Nonetheless, current estimation approaches require (correctly) specifying a model for the joint mediator
distribution, which can be difficult when there is a high-dimensional set of possibly continuous and non-continuous
mediators. In this article, we avoid the need to model this distribution, by developing a definition of interventional
effects previously suggested by VanderWeele and Tchetgen Tchetgen (2017) for longitudinal mediation. We propose
a novel estimation strategy that uses non-parametric estimates of the (counterfactual) mediator distributions. Non-
continuous outcomes can be accommodated using non-linear outcome models. Estimation proceeds via Monte Carlo
integration. The procedure is illustrated using publicly available genomic data (Huang and Pan, 2016) to assess the
causal effect of a microRNA expression on the three-month mortality of brain cancer patients that is potentially
mediated by expression values of multiple genes.
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1. Introduction
Mediation analysis is commonly used to study the effect of a treatment or exposure (A) on
an outcome (Y ) that may be transmitted through intermediate variable(s) on the causal
pathway from A to Y . Counterfactual-based definitions of natural direct and indirect effects
(Robins and Greenland, 1992; Pearl, 2001) permit decomposing the total effect of a treatment
on an outcome into a direct and an indirect effect for a single mediator, without relying on
any specific statistical models for the mediator and outcome. However, multiple possible
mediators often exist in substantive research. For example, different mediators may be
posited in trying to understand the different causal pathways from A to Y , or confounders
of the mediator-outcome relation for a mediator of interest are themselves affected by
treatment and thus perceived as competing mediators, or interventions may be designed
to affect outcome by simultaneously changing different mediators on the causal pathway
from A to Y . Extensions of natural indirect effects for a single mediator to the multiple
mediator setting are therefore complicated by the complex (possibly unknown) confounding
patterns among the different mediators. In particular, when one mediator exerts a causal
effect on another, so that the former is a confounder of the mediator-outcome relation
for the latter (henceforth termed post-treatment confounding), the assumptions needed to
(non-parametrically) identify fine-grained path-specific effects via certain mediators may be
violated (Avin et al., 2005). Consider the following example in Figure 1. The path-specific
effect along the causal path A → M1 → M3 → Y cannot be identified because M1 is a
post-treatment confounder of the M3 → Y relation. More stringent assumptions may be
imposed so that natural indirect effects defined using certain combinations of separately
(un)identifiable path-specific effects can be identified (Daniel et al., 2015; Steen et al.,
2017). But one such empirically untestable assumption that can prohibit identification when
violated is no unobserved confounding among the mediators. For example, the path-specific
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effect along the assumed path A → M1 → M2 → Y cannot be identified because U is an
unobserved confounder of M1 and M2.
[Figure 1 about here.]
Current methods for assessing natural effects with multiple mediators are therefore re-
stricted to situations where either the mediators can be causally ordered so that (combina-
tions of) path-specific effects can be identified in the presence of post-treatment confounding
(VanderWeele and Vansteelandt, 2014; Daniel et al., 2015; Steen et al., 2017; Albert et al.,
2019), or the mediators do not exert causal effects on each other, and are independent given
treatment and covariates (Lange et al., 2013; Taguri et al., 2018). Hence a limitation, shared
by all the above approaches, is that they are predicated on (correct) a priori assumptions
about the detailed causal relations between the mediators. These restrictions impede appli-
cations in most realistic settings, when the causal structure among the mediators is unknown
or cannot be (correctly) specified based on sound scientific knowledge or empirical evidence,
or the mediators are manifestations of a latent process or variable, and thus correlated.
In contrast, interventional direct and indirect effects, first introduced by Didelez et al.
(2006) and VanderWeele et al. (2014) for a single mediator, can be identified under much
weaker assumptions than natural or path-specific effects, especially when there is post-
treatment confounding of the mediator(s)-outcome relation(s). Interventional effects consider
population-level (stochastic) interventions that set the value of the mediator to a random
draw from its (counterfactual) distribution; whereas natural effects are defined in terms of
individual-level (deterministic) interventions on the mediator, which can lack scientific and
practical meaning when the treatment cannot be manipulated at the individual level (Van-
derWeele, 2013). Vansteelandt and Daniel (2017) extended the definitions to the multiple
mediator setting so that the total effect of a treatment on an outcome can be decomposed into
a direct effect and a joint indirect effect via the mediators. They further decomposed the joint
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indirect effect into separate indirect effects via each distinct mediator, and an indirect effect
via the mediators’ mutual dependence. Interventional indirect effects are defined in terms
of the underlying (possibly unknown) causal effects among the mediators. They therefore
possess valid interpretations by construction, and can be identified without prior (correct)
specification of the mediators’ causal structure, and even when mediators share hidden
common causes. Recent work discussing interventional (in)direct effects include Moreno-
Betancur and Carlin (2018), Lok (2019), and Quynh Nguyen et al. (2019), among others,
for comparisons with natural (in)direct effects; VanderWeele and Tchetgen Tchetgen (2017)
for a single longitudinal mediator; Lin and VanderWeele (2017) for multiple mediators with
a known causal ordering; and Loh et al. (2019) for comparisons with prevalent “product-of-
coefficients” methods (MacKinnon, 2000; Preacher and Hayes, 2008) assuming linear models
for all variables.
In this article, we generalize the interventional effects framework for multiple mediators to
high-dimensional mediators. A key complication when estimating current definitions of the
interventional effects is the need to correctly specify a (parametric) model for the joint dis-
tribution for all mediators conditional on treatment and all observed confounders. However,
VanderWeele and Tchetgen Tchetgen (2017) suggested the possibility of interventional effects
defined using (counterfactual) mediator distributions that depend only on treatment, and
are unconditional on the baseline confounders of the mediator(s)-outcome relation(s). Such
definitions avoid specifying models for the mediators in terms of the baseline confounders,
and can thus be particularly advantageous when there is a high-dimensional set of (non-
)continuous mediators. All current high-dimensional mediation methods for assessing indirect
effects through each distinct mediator are restricted to continuous mediators, with almost
all additionally considering only continuous outcomes, so that the product-of-coefficients
method under assumed linear models for (transformations of the) mediators and outcomes
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can be employed; see e.g., Chakrabortty et al. (2018), Huang and Pan (2016), Zhang et al.
(2016), Zhao and Luo (2016), Zhao et al. (2019), Derkach et al. (2020), and Zhao et al.
(2020) among many others. While most methods allow for either correlated errors in the joint
mediator model (thus allowing for certain forms of hidden confounding among the mediators),
or mediators to influence one another, only Zhao and Luo (2016) and Zhao et al. (2019)
allow for both within the same mediation model. In most realistic and important settings,
high-dimensional mediators that are closely linked either have complex but unknown causal
relations, or share unmeasured common causes, or both. Even in the single mediator setting,
indirect effects using the traditional product-of-coefficients method may not correspond
to those derived using the causal mediation framework, due to misspecification of non-
linear models for non-continuous mediator and outcome (MacKinnon et al., 2018). With the
increasing demand for high-dimensional mediation methods in biology, medical and public
health research, our proposal is, to the best of our knowledge, the first to allow for both
continuous and non-continuous mediators to simultaneously exist on the causal pathway
between treatment and outcome, where they can concurrently causally affect one another,
and share hidden common causes.
In this article, we therefore build on the suggestion by VanderWeele and Tchetgen Tchetgen
(2017) for a single (longitudinal) mediator to develop interventional direct and indirect effects
for high-dimensional mediators. Our proposed definitions of interventional indirect effects dif-
fer from existing definitions by Vansteelandt and Daniel (2017), Lin and VanderWeele (2017),
and Loh et al. (2019) in two respects. The first is that the decomposition of the joint indirect
effect into separate indirect effects via each mediator is invariant to the presumed (possibly
arbitrary) ordering of the mediator indices. Existing definitions assume different hypothetical
treatment levels for different subsets of the mediators, thus allowing the possibility of different
decompositions (depending on the mediator indices). The second and more pertinent differ-
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ence is that the interventional indirect effects developed in this article rely on (counterfactual)
mediator distributions that depend only on treatment, whereas existing definitions depend
on treatment and all baseline covariates. Hence estimating existing definitions demands
specifying a correct model for the joint distribution for all mediators that is congenial
with models for the marginal distribution for each mediator, all of which are conditional
on the covariates. The difficulties in correctly specifying such (parametric) mediator models
in practice are exacerbated in high-dimensional mediation settings. The definitions proposed
in this article therefore permit a novel estimation strategy that requires specifying only a
mean model for the potential outcomes, and no models for the mediators. The mediators and
outcome can be continuous or noncontinuous, with non-continuous outcomes accommodated
using non-linear outcome models. Non-parametric estimates of the (counterfactual) mediator
distributions under each treatment level are used. Estimation proceeds via Monte Carlo
integration.
The remainder of this article is as follows. In Section 2 notation is introduced, the interven-
tional direct and indirect effects are defined, and the identification assumptions are stated.
In Section 3 the novel estimation strategy that requires no models for the mediators, and
only a mean model for the outcome, is proposed. For pedagogic purposes, we will focus on
randomized studies with fewer mediators than observations in the theoretical development
of our proposed procedure. Extensions to high-dimensional mediators, and observational
studies when treatment is not randomly assigned, are then described. In Section 4 the
proposed estimation procedures are assessed via extensive simulation studies. In Section 5
the estimation strategy is illustrated using publicly-available data from a previous high-
dimensional mediation analysis (Huang and Pan, 2016) that investigated the causal effect
of a microRNA expression (miR-223) on a dichotomous three-month survival status among
patients suffering from an aggressive form of brain cancer, that is potentially mediated by
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expression values of different genes. In Section 6 we describe settings in which the proposed
and existing definitions of interventional indirect effects are (approximately) equivalent. Un-
der such (common) settings, the proposed estimation procedure simplifies current estimation
approaches (Vansteelandt and Daniel, 2017; Loh et al., 2019), by eliminating the need to
specify a model for the joint distribution of the mediators. A brief discussion is provided in
Section 7.
2. Definition and identification of interventional (in)direct effects
Consider the setting with an exposure or a treatmentA, multiple possible mediatorsM1, . . . ,Mp,
and an outcome Y . In this article, we adopt the perspective that all post-treatment con-
founders of a mediator-outcome relation for a mediator in question are themselves competing
mediators, and therefore included in the set of possible mediators. Here and throughout
subscripts in the notation for the mediators are merely used to arbitrarily index the different
mediators, and not to indicate any assumed causal (or temporal) ordering of the mediators;
e.g., M1 need not precede M2 causally (or temporally). Let Yam1···mp denote the potential
outcome for Y if, possibly counter to fact, A is set to a, when each mediator Ms is set
to the value ms, s = 1, . . . , p. Let Msa(s) denote the potential outcome for Ms if, possi-
bly counter to fact, A is set to a(s). Let Ya(0){M̃
1a(1)
···M̃
pa(1)
} denote the potential outcome
for Y under treatment A = a(0), when the mediator values are set to a random draw
from the joint (counterfactual) distribution under (hypothetical) treatment A = a(1), i.e.,
{M̃1a(1) · · · M̃pa(1)} ∼ F (M1a(1) , . . . ,Mpa(1)), where F (X) denotes a cumulative distribution
function for X. Potential outcomes where the mediators are set to random draws from the
joint counterfactual distribution are henceforth denoted by (curly) brackets in the subscripts.
Let Ya(0)M̃
1a(1)
···M̃
pa(p)
denote the potential outcome under treatment A = a(0), when the value
of each mediator is set to a random draw from the marginal (counterfactual) distribution
that does not depend on any other mediator, i.e., M̃sa(s) ∼ F (Msa(s)), s = 1, . . . , p. Let
L denote all observed baseline (i.e., unaffected by treatment) covariates that may affect
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any of (A,M1, . . . ,Mp, Y ). Here and throughout, the joint and all marginal distributions
for the (counterfactual) mediators are unconditional on L. The average potential outcomes
(hereafter termed “estimands”) are respectively defined as:
E
(
Ya(0){M̃
1a(1)
···M̃
pa(1)
}
)
=
∫
E(Ya(0)m1···mp) dFM1a(1) ,··· ,Mpa(1) (m1, · · · ,mp), and (1)
E
(
Ya(0)M̃
1a(1)
···M̃
pa(p)
)
=
∫
E(Ya(0)m1···mp) dFM1a(1) (m1) · · · dFMpa(p) (mp). (2)
2.1 Interventional (in)direct effects for multiple mediators
The interventional effects comparing estimands (1) and (2) under different hypothetical
treatment levels for a binary treatment A are defined as follows. Let g denote a user-specified
link function, such as the log link g(x) = log(x), or the “logit” link g(x) = log{x/(1 − x)}.
Define the total effect as:
g
{
E
(
Y1{M̃11···M̃p1}
)}
− g
{
E
(
Y0{M̃10···M̃p0}
)}
,
which can be decomposed into the direct effect, defined as:
g
{
E
(
Y1{M̃11···M̃p1}
)}
− g
{
E
(
Y0{M̃11···M̃p1}
)}
, (3)
and the (joint) indirect effect, defined as:
g
{
E
(
Y0{M̃11···M̃p1}
)}
− g
{
E
(
Y0{M̃10···M̃p0}
)}
. (4)
The indirect effect via each mediator Ms, s = 1, . . . , p, is defined as:
g
{
E
(
Y0M̃10···M̃s−1,0 M̃s1 M̃s+1,0···M̃p0
)}
− g
{
E
(
Y0M̃10···M̃p0
)}
. (5)
Changing only the marginal counterfactual distribution of Ms from treatment to control
implies an “overall” effect of treatment on Ms that is unconditional on any other mediators.
This effect therefore marginalizes over all (underlying) causal effects along (unknown) paths
from treatment to the mediator in question that may intersect other causally antecedent me-
diators. Hence the interventional indirect effect through a mediator can be readily interpreted
as the combined causal effect along all (underlying) paths from treatment to the mediator in
question, then directly to the outcome. Continuing the example shown in Figure 1, the
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indirect effect through M3 is the combined effect along the paths A → M3 → Y and
A → M1 → M3 → Y . Further interpretations are deferred to the simulation studies in
Section 4 and the illustration in Section 5.
Note that in the first term of (5), only the mediator in question Ms is drawn from its
distribution under treatment a(s) = 1; all other mediators are drawn from their distributions
under control, i.e., a(k) = 0 for k = 1, . . . , p, k 6= s. This definition of the indirect effect
(5) is especially amenable to settings with high-dimensional mediators because it does not
require fixing the hypothetical treatments for the other mediators at different levels, and
is hence invariant to the chosen (possibly arbitrary) ordering of the mediator indices. In
contrast, existing definitions (Vansteelandt and Daniel, 2017; Loh et al., 2019) set a(k) = 1
for k = 1, . . . , s−1, and a(k) = 0 for k = s+1, . . . , p, so that different definitions are possible
depending on the mediator indices, although the conceptual interpretations remain the same.
Lastly, the difference between the joint indirect effect (4) and the sum of the separate
indirect effects (5) for all mediators can be further partitioned into:
[
g
{
E
(
Y0{M̃11···M̃p1}
)}
− g
{
E
(
Y0M̃11···M̃p1
)}]
−
[
g
{
E
(
Y0{M̃10···M̃p0}
)}
− g
{
E
(
Y0M̃10···M̃p0
)}]
, (6)
and
[
g
{
E
(
Y0M̃11···M̃p1
)}
− g
{
E
(
Y0M̃10···M̃p0
)}]
−
p∑
s=1
[
g
{
E
(
Y0M̃10···M̃s−1,0 M̃s1 M̃s+1,0···M̃p0
)}
− g
{
E
(
Y0M̃10···M̃p0
)}]
. (7)
Following Vansteelandt and Daniel (2017), we refer to (6) as the indirect effect via the
mediators’ mutual dependence. This indirect effect describes how treatment affects the rela-
tionships between the mediators, which subsequently affects the outcome, and thus cannot be
attributed to any single mediator. We term the indirect effect in (7) as the “remainder” effect
after removing the indirect effect via the mutual dependence (6) from the difference between
the joint indirect effect (4) and the sum of the separate indirect effects (5). Interpretations
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and closed-form expressions for the indirect effects (6) and (7), under the setting with two
mediators and (non-)linear models for the mediators (and outcome), are provided in the Web
Appendix. For example, when the mean model for the outcome is linear and the mediators
are normally distributed, the indirect effect via the mediators’ mutual dependence (6) is
non-zero if and only if the covariance of the mediators is affected by treatment and the
mediator-mediator interaction effect on the outcome is non-zero. When the mean model for
the outcome is log-linear and the mediators are normally distributed, this indirect effect is
non-zero if and only if the covariance of the mediators is affected by treatment and the main
effects of the mediators on the outcome are both non-zero.
2.2 Assumptions for identification
Identification of the interventional effects requires the following assumptions, where “⊥”
denotes conditional independence:
Yam1···mp ⊥ A|L ∀ a,m1, . . . ,mp; (8)
Yam1···mp ⊥ {M1 · · ·Mp}|(A = a, L) ∀ a,m1, . . . ,mp; (9)
{M1a · · ·Mpa} ⊥ A|L ∀ a. (10)
Assumptions (8) and (10) state that the effect of treatment A on outcome Y , and the
effects of treatment A on all mediators, are unconfounded conditional on L. Assumption (9)
states that there is sufficient information observed in L so that the association between
any of the mediators (M1, . . . ,Mp) and outcome Y is unconfounded within levels of the
covariates L. Because this assumption is not empirically testable, all baseline measurements
of the mediators and the outcome (prior to treatment being received) should be adjusted
for in practice, even when treatment is randomly assigned. We refer readers to Smith and
VanderWeele (2019) for implications when this assumption is violated, and recommended
sensitivity analyses.
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3. Estimation of interventional (in)direct effects
In this section we develop a novel estimation strategy that requires only an outcome model,
and no models for the mediators. The strategy exploits the proposed definitions of the
interventional effects using (counterfactual) mediator distributions that are unconditional
on any covariates. For pedagogic purposes, we will first assume that there are sufficient
observations for an unpenalized outcome model, conditional on treatment, all mediators,
and covariates, to be fitted to the observed data. We will further assume that treatment
is randomly assigned so that both independence assumptions (8) and (10) are satisfied
unconditionally on L. Extensions to high-dimensional mediators, and observational studies
with non-randomly assigned treatments, are presented in later sections.
3.1 Randomly assigned treatment with an unpenalized outcome model
Estimators of the proposed interventional (in)direct effects are obtained as follows:
A0. Fit an outcome model, conditional on treatment, mediators, and covariates, to the observed
data, e.g., E(Y |A,M1, . . . ,Mp, L). The outcome model can be expressed as a function of its in-
puts, e.g., E(Y |A = a,M1 = m1, . . . ,Mp = mp, L) = h(a,m1, . . . ,mp, L), where h(·) is a user-
specified function. The observed values of the covariates L for each individual are assumed
to be fixed and invariant to different values of the treatment a and counterfactual mediator
values (denoted by m1, . . . ,mp). Denote the estimated function by ĥ(a,m1, . . . ,mp, L).
A1. Construct the duplicated data for each individual as shown in Table 1. The hypothetical
treatment levels a(0) and a(1) are chosen so that the interventional direct effect (3) is the dif-
ference between the (transformed) estimands in the last and penultimate rows, and the joint
indirect effect (4) is the difference between the (transformed) estimands in the penultimate
and first rows.
[Table 1 about here.]
A2. For each row of Table 1, randomly draw the counterfactual mediator values {M̃1a(1) · · · M̃pa(1)}
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jointly from the observed treatment group A = a(1). Because treatment is randomly assigned,
there are no confounders of the treatment and the (counterfactual) mediators, and assump-
tion (10) is satisfied unconditionally on L. Randomly select an individual whose observed
treatment is A = a(1), then set the counterfactual mediators {M̃1a(1) · · · M̃pa(1)} to the selected
individual’s observed values {M1 · · ·Mp}.
A3. Impute the expected potential outcomes as predictions ĥ(a(0), M̃1a(1) , . . . , M̃pa(1) , L) from
the fitted outcome model in step A0.
A4. Repeat steps A2 and A3 to account for the variability in the (counterfactual) mediator val-
ues, thereby obtaining the (Monte Carlo averaged) imputed potential outcomes E
(
Ya(0){M̃
1a(1)
···M̃
pa(1)
}|L
)
for each individual.
A5. For each unique value of {a(0), a(1)} in Table 1, calculate the average imputed potential
outcome E
(
Ya(0){M̃
1a(1)
···M̃
pa(1)
}
)
across all individuals in the observed sample, which in doing
so, averages over the empirical distribution of the covariates L. The estimators of the direct
effect (3) and joint indirect effect (4) are obtained by plugging in the sample averages for
the unknown (population) quantities.
Next, we estimate the separate indirect effects via each mediator. In general, the potential
outcome Ya(0)M̃
1a(1)
···M̃
pa(p)
is unobservable, even when the hypothetical treatments all equal
the observed treatment (i.e., a(0) = a(1) = . . . = a(p) = A). This is because each counter-
factual mediator M̃sa(s) , even under the observed treatment a
(s) = A, has to be drawn from
its marginal (counterfactual) distribution that does not depend on any other mediators by
definition. In contrast, the observed values {M1 · · ·Mp} are jointly distributed according to
some (unknown) distribution for all the mediators. Estimating the indirect effects via each
mediator therefore requires randomly sampling (counterfactual) mediator values from their
marginal distributions, and proceeds as follows:
B1. Construct the duplicated data for each individual as shown in Table 2. Set all hypothetical
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treatments in the first row to 0; i.e., a(0) = a(1) = . . . = a(p) = 0. For s = 1, . . . , p, set the
hypothetical treatments in row s+ 1 to those in the first term of the interventional indirect
effect via mediator Ms as defined in (5); i.e., a
(s) = 1 in row s + 1, and 0 otherwise. The
hypothetical treatment levels are chosen so that the interventional indirect effect via each
mediator Ms corresponds to the difference between the (transformed) estimands in rows s+1
and 1. In the last row, set a(0) = 0 and a(1) = . . . = a(p) = 1. The interventional indirect effect
via the mediators’ mutual dependence (6) is thus the difference between (i) the difference in
(transformed) estimands in the penultimate and first rows of Table 1, and (ii) the difference
in (transformed) estimands in the last and first rows of Table 2.
[Table 2 about here.]
B2. In each row of Table 2, for column s = 1, . . . , p, randomly sample the counterfactual
mediator M̃sa(s) , unconditionally on the other mediators, from the observed treatment group
A = a(s). This can be carried out by randomly selecting an individual whose observed treat-
ment is A = a(s), then setting the counterfactual mediator M̃sa(s) to the selected individual’s
observed value Ms. Because the randomly assigned treatment is jointly independent of all
the (counterfactual) mediators when assumption (10) holds, it implies that the treatment is
marginally independent of each (counterfactual) mediator, unconditionally on L.
B3. Impute the expected potential outcomes as a prediction ĥ(0, M̃1a(1) , . . . , M̃pa(p) , L) from the
fitted outcome model in step A0.
B4. Repeat steps B2 and B3 to account for the variability in the (counterfactual) mediator val-
ues, thereby obtaining the (Monte Carlo averaged) imputed potential outcomes E
(
Ya(0)M̃
1a(1)
···M̃
pa(1)
|L
)
for each individual.
B5. For each unique value of {a(0), a(1), . . . , a(p)} in Table 2, calculate the average imputed
potential outcome E
(
Ya(0)M̃
1a(1)
···M̃
pa(p)
)
across all individuals in the observed sample. The
estimators of the interventional indirect effect via each mediator Ms (5) are obtained by
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plugging in the sample averages for the unknown (population) quantities. The estimator of
the indirect effect via the mediators’ mutual dependence (6) is similarly obtained using the
sample averages in the second and first rows of Table 1, and the last and first rows of Table 2.
3.1.1 Remarks. Unbiased estimation of the interventional effects therefore depends on
correctly specifying an outcome model conditional on treatment, mediators, and covariates
that is unbiased for the mean model for the potential outcomes; i.e., ĥ(a,m1, . . . ,mp, L = l)
converges in probability to E
(
Yam1···mp |L = l
)
for each (observed) value of l. The consistency
of the estimator under the identifying assumptions (8)–(10) is shown in Web Appendix A.
Standard errors can be estimated using a non-parametric percentile bootstrap procedure
(Efron and Tibshirani, 1994) that randomly resamples observations with replacement, then
repeating steps A0 – A5 and B1 – B5 for each bootstrap sample.
In principle, when given the mediators’ causal ordering, the mediators’ joint probability
density function can be factorized into a product of the individual mediator density functions,
conditional on their causally antecedent mediators. The counterfactual mediators can then be
randomly sampled using these conditional distributions in steps A2 and B2 of the proposed
estimation procedure. We emphasize that the proposed estimation strategy remains valid
even when the (counterfactual) mediators’ joint density may be factorized according to an
incorrectly specified causal ordering. Nonetheless, a potential shortcoming is the imposition of
parametric models for each individual mediator distribution conditional on other mediators.
Using parametric models may conceptually resemble existing methods (Vansteelandt and
Daniel, 2017; Lin and VanderWeele, 2017), albeit targeting different definitions of inter-
ventional indirect effects as described earlier in this article. But as we will describe later
in Section 6, the interventional effects proposed in this article are equivalent to existing
definitions by Vansteelandt and Daniel (2017) under most common settings. Finally, we
reiterate that the proposed estimators of interventional indirect effects put forth in this article
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draw the (counterfactual) mediators from their marginal distributions, as in VanderWeele
and Tchetgen Tchetgen (2017). This permits the proposed estimation strategy using non-
parametric estimates of the mediator distributions, thus avoiding (i) assumptions on the
causal structure among the mediators, and (ii) modeling the mediators’ joint distribution.
3.2 High-dimensional mediators
In this section, we consider high-dimensional mediation settings with fewer observations
than mediators (and covariates). Separate mediation analyses can lead to biased estimates
of indirect effects because merely omitted mediators can act as unobserved (post-treatment)
confounders of the mediator(s) in question and the outcome, thus violating assumption
(9). Recall the example in Figure 1, where M1 and M2 are confounders of the M3 − Y
relation. A single mediation analysis for M3 that ignores either M1 or M2, or both, will
yield biased estimates of the indirect effect via M3. In this section, we propose a strategy
to estimate the separate indirect effects via each mediator, by focusing on each distinct
mediator Ms, s = 1, . . . , p, in turn. For the mediator Ms in question, possible confounding of
the mediator-outcome relation (by other mediators or possibly high-dimensional covariates)
is carefully adjusted for to ensure unbiased estimation of the interventional indirect effect.
3.2.1 Outcome model. First, fit a penalized regression model for the outcome to the
observed data. Here and throughout, we will consider an elastic net penalty (Zou and Hastie,
2005), which is a compromise between the ridge regression penalty and the lasso penalty. The
elastic net penalty is especially useful when there are many correlated predictor variables,
and has been applied to different gene expression datasets with highly correlated genes
(Friedman et al., 2010). Because evaluating the indirect effect via Ms requires assessing the
associations between Ms and Y , (prematurely) shrinking the coefficient of Ms to zero can
lead to biased inference. The coefficient for Ms is therefore better left unpenalized, e.g., by
setting its penalty factor to zero, to retain Ms in the outcome model. Denote the subset
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of the remaining mediators and covariates with non-zero (penalized) coefficients by Ms,
where the subscript emphasizes the focus on mediator Ms. Denote the resulting (penalized)
outcome model by h(A,Ms,Ms), where the dependence on only the selected variables in
Ms is explicit.
3.2.2 Indirect effect via each distinct mediator. To estimate the indirect effect via Ms,
carry out steps B1 – B5 using only rows s + 1 and 1 of Table 2. Predictions from the
(penalized) outcome model h(A,Ms,Ms) fitted to the observed data are used to impute
potential outcomes in step B4.
3.3 Observational studies with non-randomly assigned treatments
When treatment is not randomly assigned, the counterfactual mediator values used to
construct the duplicated data in the estimation procedure cannot be sampled by merely
selecting mediator values at random within each observed treatment group. The observed
baseline confounders L of the treatment-mediator(s) and treatment-outcome relations have
to be adjusted for toward ensuring that the identifying assumptions (8) and (10) hold. For
example, the counterfactual density for mediator Ms when setting A to a is:
f(Msa) =
∫
f(Ms|A = a, L = l)f(L = l)f(L = l|A = a)−1 dFL|A=a(l)
= Pr(A = a)
∫
f(Ms|A = a, L = l) Pr(A = a|L = l)−1 dFL|A=a(l), a = 0, 1.
The above result motivates a modified estimation procedure for non-randomly assigned
treatments, by sampling the (observed) mediator values with probability proportional to
the inverse of the conditional probability of receiving the observed treatment given the
confounders. For example, suppose that a(s) = 0. Consider an individual in the treatment
group A = 0 with covariate values L = l and observed mediator value Ms. The sampling
probability of this particular individual’s value of Ms is Pr(A = 0|L = l)−1/{
∑
i Pr(A =
0|L = li)−11 (Ai = 0)}, where the sum in the denominator is over all individuals i (as indexed
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by the i superscripts without brackets) with covariate values L = li in the (same) treatment
group Ai = 0. The (counterfactual) mediator value(s) can be readily sampled by randomly
selecting an individual from the treatment group A = a(s) according to the aforementioned
sampling probabilities, then setting the counterfactual mediator to the selected individual’s
observed mediator value(s). In practice, the probabilities of the observed treatments Pr(A =
a|L), a = 0, 1, may be estimated using predictions from a (saturated) logistic regression
model fitted to the observed data, with the treatment as the dependent variable, and main
effects (and when feasible, higher order and interaction effects) for the covariates as the
predictors.
4. Simulation studies
Two simulation studies were conducted to empirically assess the operating characteristics
of the proposed estimation strategy in finite samples across different settings. Details of
the procedures and results of these simulation studies are deferred to Web Appendix B. To
provide an overview, in study 1, we considered a setting with two (continuous) mediators
where one was causally affected by the other. The estimators of the interventional effects
proposed in this article were compared with existing estimators of natural effects (Steen
et al., 2017) that required stricter identification assumptions. We considered an extensive
range of settings where the causal ordering of the mediators was either correctly or incorrectly
assumed, and unobserved confounding of the mediators was either present or absent. In study
2, settings with high-dimensional (non-continuous) mediators were considered for assessing
the indirect effect estimators proposed in Section 3.2. We considered binary outcomes in
study 1, and both continuous and binary outcomes in study 2.
The results of the simulation studies showed that estimators of the existing natural indirect
effects were unbiased only when the identifying assumptions were met; i.e., the mediators’
causal ordering was correctly assumed, and there was no unobserved confounding of the
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mediators. As expected, when at least one of the assumptions was violated, estimates were
biased even at large sample sizes. In contrast, estimators of the interventional effects proposed
in this article were unbiased under all the considered settings. The proposed estimation
strategy for high-dimensional mediators was able to detect the mediators through which the
(non-zero) indirect effects were transmitted with high probability (90% or above) empirically.
In general, the interventional indirect effects were unbiasedly estimated, with empirical
coverage of the confidence intervals at approximately their nominal levels. However, under
extreme scenarios when (i) the mediators were strongly associated with each other, and (ii)
true mediators were only indirectly affected by treatment (via other mediators), and (iii) the
outcome was binary, the estimated indirect effects were empirically biased in finite samples.
The biases were due to the penalized logistic regression model under-selecting the relevant
predictors which were strongly correlated with irrelevant predictors, resulting in inadequate
adjustment for common causes (and intermediate variables) of a mediator’s effect on the
outcome. Nonetheless, the biases shrunk to zero empirically when the unpenalized MLE
of the outcome model (which did not require variable selection) was used to estimate the
indirect effects. More complex working solutions to reduce such finite sample biases are
described in the Discussion section and deferred to future work.
5. Illustration with an example dataset
We illustrate the proposed estimation strategy using publicly available data from a previous
high-dimensional mediation analysis by Huang and Pan (2016). Huang and Pan assessed
whether the causal effect of the microRNA miR-223 expression (the treatment of interest)
on mortality within three months due to glioblastoma multiforme (GBM), a malignant brain
tumor, was mediated by expression values of different genes in the tumor genome. Expression
values for p = 1220 genes (with no missing data) from 490 patients suffering from GBM were
included in the online supplemental materials of Huang and Pan (2016). Interventional effects
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are suitable for such high-dimensional mediator settings because the mediators’ internal
causal structure, such as gene regulation networks or protein signaling networks, are often
unknown in practice. For the purposes of illustrating the proposed estimation strategy, we
made the following simplifying assumptions. We dichotomized the miR-223 expression at the
empirical median so that A = 1 if the expression was above the median, or 0 otherwise. We
used a dichotomous indicator of whether death from GBM had occurred in the first three
months as the outcome (Y ). Among the 490 patients, 44 died within the first three months
(Y = 1). We assumed that the patients lost to follow-up prior to three months (four in
the A = 0 group, and five in the A = 1 group) were alive (Y = 0). We assumed that the
baseline demographic variables in the publicly available data (age at diagnosis, gender, and
ethnicity), which we jointly denoted by L, were sufficient for the identifying assumptions
(8)–(10) to hold. In practice, a richer set of (baseline) covariates should be adjusted for in
substantive analyses to reduce the possibility of biases due to unobserved confounding.
The proposed estimation strategy for high-dimensional mediators described in Section 3.2
was carried out. Estimating each indirect effect required fitting only an outcome model to the
observed data, and did not require assuming any model for the mediators. For each mediator
Ms, s = 1, . . . , p, in turn, a penalized logistic regression model for the binary outcome using
an elastic net penalty was fitted using the glmnet package (Friedman et al., 2010) in R.
The value of the tuning parameter that controlled the overall strength of the penalty in
each candidate model was selected using n-fold (or “leave-one-out”) cross-validation on the
misclassification error. The default sequence of models in the cv.glmnet function employs
K = 100 (equally-spaced) values of the penalty between λmin = ελmax, ε = 10
−4, and λmax
(on the log scale), with λmax computed using the empirical data (Friedman et al., 2010). To
ensure a wider spread of models and to improve the convergence properties for a nonlinear
model, we instead set K = 200 and λmin = εp/n, ε = 10
−6. We further forced treatment (A),
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the baseline covariates (L), and the mediator in question (Ms) into the outcome model by
setting their penalty factors to zero. All other arguments were set to their default values.
Because the resulting penalized coefficient estimates may be biased (Hastie et al., 2009, page
91), we refitted the (un)penalized regression model to the selected set of predictors (with
non-zero coefficient estimates in the previous step) following the “relaxed LASSO” approach
(Meinshausen, 2007) to obtain the estimated outcome model.
Because treatment was not randomly assigned, counterfactual mediator values were sam-
pled using the proposed weights in Section 3.3 under a saturated logistic regression model for
treatment conditional on the baseline covariates. For each mediator, we plotted the estimated
coefficient of treatment on the mediator in question in a simple linear regression, and the
estimated coefficient of the mediator in the (penalized) logistic outcome model, in Figure 2.
Each panel corresponded to one of the nine (overlapping) sets of mediators defined in Table
2 of Huang and Pan (2016). We refer readers to Huang and Pan for details of the biological
functions of each gene set.
[Figure 2 about here.]
Non-parametric 95% percentile bootstrap confidence intervals (CIs) were constructed us-
ing 2000 bootstrap samples that randomly resampled observations with replacement and
repeated the estimation procedure for each sample. Genes whose 95% CIs excluded zero
are displayed in Table 3. The interventional indirect effect via an individual gene can be
interpreted using the following example. The odds of death from GBM within three months
due to shifting the marginal distribution of the CLEC5A gene expression from those with
observed miR-223 expressions above the median to those below the median, while holding the
distributions of all other gene expressions fixed among those with miR-223 expressions below
the median, was estimated to increase by exp(0.34) ≈ 1.40 times (95% CI = (1.13, 1.97)).
To compare our results with those in Huang and Pan, we indicated in Table 3 which
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gene set(s) each distinct gene belonged to. Huang and Pan found that all nine gene sets
significantly mediated the causal effect of miR-223 expression on GBM mortality within three
months (with p-values less than 0.05). We (similarly) found that each gene set contained at
least one gene with a non-zero interventional indirect effect whose 95% CI excluded zero.
Because several simplifying assumptions were made for the sole purpose of illustrating the
proposed estimation strategy, substantive conclusions about the biological significance of the
statistically significant mediators are beyond the scope of this article.
[Table 3 about here.]
6. Comparison
In this section, we argue that in common settings, the interventional effects proposed in this
article are equal to existing definitions by Vansteelandt and Daniel (2017). In particular, the
existing definitions rely on (counterfactual) mediator distributions that depend on treatment
and all baseline covariates, including confounders of the mediator(s)-outcome relation(s).
Suppose that all mediators are continuous, so that linear mean models for the mediators
(conditional on L) may be assumed. Suppose that the outcome is dichotomous, and suffi-
ciently rare so that the logit link in a mean model for the outcome can be approximated by
the log link. When (i) the outcome model has main effects only, and (ii) the effect of treatment
on the mediators is not moderated by the confounders (i.e., there are no interaction terms
involving treatment in the mediator mean models), the proposed interventional effects are
equal to existing definitions. Detailed results are provided in Web Appendix C.
7. Conclusion
In this article, we have developed interventional effects for high-dimensional mediators that
permit a novel estimation strategy allowing for any mean model for the outcome, and requir-
ing no models for the mediators. There are several avenues of possible future related research.
The proposed estimation strategy for high-dimensional mediators is designed to deliver
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reasonable approximations of the indirect effects through each distinct mediator, by selecting
other variables (including mediators) that may be confounders of the mediator-outcome
relation in question. To increase the chances of detecting such confounders, a separate
(penalized regression) model for the mediator, conditional on all other mediators, treatment,
and covariates, can be employed. The selected predictors (with non-zero coefficients) in
either the penalized outcome model, or the penalized mediator model, can then be included
in a new (unpenalized) outcome model to impute potential outcomes for estimating the
interventional indirect effects. The use of separate outcome and mediator models is inspired
by double selection principles (Belloni et al., 2014), where in settings without mediators, the
(partial) associations between the outcome and the covariates, and between the treatment
and the covariates, are evaluated. We acknowledge that specifying mediator models may
appear contradictory to the key feature of our proposal that avoids modeling the relations
between the mediators. But we emphasize that the (penalized) regression model for each
mediator in question is used merely to select possible confounders of the mediator-outcome
relation, by essentially viewing the other mediators as possible confounders. These models
do not assume (or empirically imply) any causal structure among the mediators, and do not
require specifying a model for the joint distribution of the mediators.
When selecting a subset of the mediators for further investigation, a threshold that either
is pre-determined, such as in Huang and Pan (2016), or controls the familywise error rate
under multiple testing scenarios, such as in Derkach et al. (2020), can be used. When
further interest is in estimating the direct, joint, or mutual indirect effects, a separate
penalized regression model for the outcome (conditional on all the mediators, covariates,
and treatment) must be fitted to the observed data for predicting the potential outcomes in
Table 1, and in the first and last rows of Table 2, of the estimation strategy in Section 3.1. The
estimated interventional indirect effects via each distinct mediator can be used to determine
A
cc
ep
te
d
A
rt
ic
le
This article is protected by copyright. All rights reserved.
22 Biometrics, 000 0000
the penalties; e.g., the indirect effects can be used in place of the product of coefficients in the
penalties for the pathway lasso (Zhao and Luo, 2016). High-dimensional mediation methods
that employ principal components analysis, such as Huang and Pan (2016) and Zhao et al.
(2020), can be used to select mediators with high loadings in the principal components.
Substantive comparisons of the indirect effects through specific selected (sets of) mediators
using such approaches, with the interventional indirect effects developed in this article, may
be made in future work. Establishing theoretical properties to ensure valid inference of
the proposed Monte Carlo-based estimators, especially following mediator selection, is an
area of future development. Unbiased estimation of the interventional effects defined in this
article depends on correctly specifying a mean model for the outcome. Vansteelandt et al.
(2012) recommend using sufficiently rich outcome models that e.g., include higher-order
or interaction terms between treatment and mediators, or between mediators. Assessing
robustness to misspecification of the outcome model, e.g., due to omitting such interaction
terms, is a direction for future research. Other more general non-parametric prediction
methods for the potential outcomes that leverage data-adaptive techniques (Dı́az et al.,
2019; Benkeser, 2020) can also be considered. Extending such machine learning methods to
high-dimensional settings requires further work to avoid the need for inverse weighting by
the joint mediator density.
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Figure 1. Causal diagram for an example with three mediators, two of which share an
unobserved confounder U . Observed variables are drawn as rectangular nodes and unobserved
variables are drawn as round nodes.
A M1 U M2 M3 Y
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Figure 2. Scatterplots of the (penalized) regression coefficients in the linear mediator
and logistic outcome models for the GBM data set. Each point corresponds to a distinct
mediator, with the coefficient of treatment on the mediator in question on the vertical axis
(“A → M”), and the coefficient of the mediator on the outcome on the horizontal axis
(“M → Y ”). The size and color of the points are proportional to the (absolute) magnitudes
of the indirect effects, with larger points and darker (red) hues indicating indirect effect
estimates further from zero. Mediators whose 95% CIs excluded zero are circled in black.
Each panel corresponds to one of the nine sets of mediators described in Huang and Pan.
This figure appears in color in the electronic version of this article, and any mention of color
refers to that version.
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Table 1
Duplicated data for each individual when estimating the direct and joint indirect effects. The counterfactual
mediators {M̃1a(1) · · · M̃pa(1)} are randomly drawn (jointly) from the observed treatment group A = a(1). The column
L is omitted for simplicity.
a(0) a(1) {M̃1a(1) · · · M̃pa(1)} E
(
Ya(0)M̃
1a(1)
···M̃
pa(1)
|L
)
0 0 {M̃10 · · · M̃p0} ĥ(0, M̃10, . . . , M̃p0, L)
0 1 {M̃11 · · · M̃p1} ĥ(0, M̃11, . . . , M̃p1, L)
1 1 {M̃11 · · · M̃p1} ĥ(1, M̃11, . . . , M̃p1, L)
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Table 2
Duplicated data for each individual when estimating the separate indirect effects via each mediator. There are t + 2
rows for a binary treatment A. The counterfactual mediators M̃sa(s) are randomly drawn from the observed
treatment group A = a(s), s = 1, . . . , p. The column L is omitted for simplicity.
a(0) a(1) a(2) · · · a(p−1) a(p) M̃1a(1) M̃2a(2) · · · M̃p−1,a(p−1) M̃pa(p) E
(
Ya(0)M̃
1a(1)
···M̃
pa(p)
|L
)
0 0 0 · · · 0 0 M̃10 M̃20 · · · M̃p−1,0 M̃p0 ĥ(0, M̃10, . . . , M̃p0, L)
0 1 0 · · · 0 0 M̃11 M̃20 · · · M̃p−1,0 M̃p0 ĥ(0, M̃11, . . . , M̃p0, L)
0 0 1 · · · 0 0 M̃10 M̃21 · · · M̃p−1,0 M̃p0 ĥ(0, M̃10, . . . , M̃p0, L)
...
...
...
...
...
...
...
...
...
...
...
...
0 0 0 · · · 1 0 M̃10 M̃20 · · · M̃p−1,1 M̃p0 ĥ(0, M̃10, . . . , M̃p0, L)
0 0 0 · · · 0 1 M̃10 M̃20 · · · M̃p−1,0 M̃p1 ĥ(0, M̃10, . . . , M̃p1, L)
0 1 1 · · · 1 1 M̃11 M̃21 · · · M̃p−1,1 M̃p1 ĥ(0, M̃11, . . . , M̃p1, L)
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Table 3
Estimates (“Est.”) on the log-odds scale, and non-parametric bias-corrected and accelerated bootstrap 95%
confidence intervals (“CIs”), for the interventional indirect effects via each distinct gene in the GBM data set. Only
genes whose 95% CIs excluded zero are displayed. The genes are ordered by increasing lower bound of their 95% CI.
Each gene either belongs (“1”) or does not belong (“0”) to a gene set described in Huang and Pan. The gene sets in
the column headings are labelled as (i) GO0009607, (ii) GO0051707, (iii) GO0016064, (iv) GO0019724, (v)
GO0045088, (vi) GO0002443, (vii) GO0002285, (viii) GO0002764, and (ix) GO0006952. All results are rounded to
two decimal places.
Gene Est. 95% CI (i) (ii) (iii) (iv) (v) (vi) (vii) (viii) (ix)
FYB -0.61 -1.18 -0.27 0 0 0 0 0 0 0 1 0
SAA2 -0.22 -0.68 -0.06 0 0 0 0 0 0 0 0 1
ADM -0.04 -0.56 -0.01 1 1 0 0 0 0 0 0 0
NUPR1 -0.09 -0.53 -0.06 0 0 0 0 0 0 0 0 1
FCN2 -0.17 -0.50 -0.12 0 0 0 0 0 0 0 0 1
IRF5 -0.25 -0.49 -0.07 1 1 0 0 0 0 0 0 1
ARRB2 -0.12 -0.47 -0.04 0 0 0 0 1 1 0 1 1
SPON2 -0.10 -0.45 -0.03 0 0 0 0 0 0 0 0 1
CD226 -0.29 -0.44 -0.10 1 0 1 1 1 1 0 1 1
NCAM1 -0.07 -0.39 -0.02 0 0 0 0 0 0 0 0 1
MAPK8IP2 -0.10 -0.39 -0.02 0 0 0 0 0 0 0 0 1
BTN3A1 -0.18 -0.35 -0.01 0 0 0 0 0 0 0 1 0
ECM1 -0.04 -0.29 -0.00 0 0 0 0 0 0 0 0 1
CYP11A1 -0.10 -0.29 -0.01 1 1 0 0 0 0 0 0 0
C6 -0.18 -0.29 -0.03 0 0 1 1 0 1 0 0 1
CFH 0.11 0.02 0.40 0 0 0 0 0 0 0 0 1
LGALS8 0.32 0.02 0.57 0 0 0 0 0 0 1 0 0
SPHK1 0.23 0.03 0.50 0 0 0 0 0 0 0 0 1
SPP1 0.29 0.03 0.62 0 0 0 0 0 0 0 0 1
SERPINE1 0.29 0.04 0.69 1 1 0 0 0 0 0 0 1
TSPO 0.27 0.05 0.56 1 1 0 0 0 0 0 0 0
PIK3CD 0.27 0.05 0.77 0 0 0 0 0 1 0 1 1
FZD5 0.13 0.06 0.36 1 1 0 0 0 0 0 0 0
IRF1 0.19 0.06 0.49 1 1 0 0 1 0 0 1 1
ITK 0.39 0.06 0.59 0 0 0 0 0 0 0 1 1
MAPK1 0.25 0.06 0.46 1 1 0 0 1 0 0 1 1
A2M 0.21 0.09 0.64 0 0 0 0 1 0 0 0 1
GBP3 0.19 0.12 0.49 1 1 0 0 0 0 0 0 1
CLEC5A 0.34 0.12 0.68 1 1 0 0 0 0 0 0 1
